[Pharmacologic action of sympathomimetics].
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000661:Amphetamine / Q000494:pharmacology; D000758:Anesthesia; D000804:Angiotensin II / Q000494:pharmacology; D003521:Cyclopropanes / Q000494:pharmacology; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008616:Mephentermine / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013566:Sympathomimetics / Q000145:classification / Q000494:pharmacology*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D003521:Cyclopropanes; D008996:Monoamine Oxidase Inhibitors; D013566:Sympathomimetics; D000804:Angiotensin II; D010656:Phenylephrine; D008680:Metaraminol; D011433:Propranolol; D000661:Amphetamine; D004809:Ephedrine; D008729:Methoxamine; D007545:Isoproterenol; D008616:Mephentermine; D009638:Norepinephrine; D004837:Epinephrine
Action pharmacologique de sympathomimétiques.